Bayer A.G.Bayer A.G.Bayer A.G.

Bayer A.G.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪26.84 B‬USD
−0.36USD
‪−3.18 B‬USD
‪51.50 B‬USD
‪3.93 B‬
Beta (1Y)
0.26

About BAYER AG NA O.N.


CEO
William N. Anderson
Headquarters
Leverkusen
Website
Founded
1952
FIGI
BBG000BYMB76
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XS2684846806
Bayer 7% 83
Yield to maturity
6.66%
Maturity date
Sep 25, 2083
M
BAYZ4067527
Monsanto Company 4.65% 15-NOV-2043
Yield to maturity
6.55%
Maturity date
Nov 15, 2043
B
BAYZ5705356
Bayer US Finance LLC 6.875% 21-NOV-2053
Yield to maturity
6.48%
Maturity date
Nov 21, 2053
M
BAYZ3673141
Monsanto Company 5.875% 15-APR-2038
Yield to maturity
6.45%
Maturity date
Apr 15, 2038
XS268482601
BAYER AG 2023/2083
Yield to maturity
6.41%
Maturity date
Sep 25, 2083
M
BAYZ3875861
Monsanto Company 3.6% 15-JUL-2042
Yield to maturity
6.35%
Maturity date
Jul 15, 2042
B
BAYZ5530169
Bayer US Finance II LLC 4.65% 15-NOV-2043
Yield to maturity
6.33%
Maturity date
Nov 15, 2043
B
USU07265AH1
BAY.US FI.II. 18/48 REGS
Yield to maturity
6.29%
Maturity date
Jun 25, 2048
M
BAYZ4140706
Monsanto Company 4.7% 15-JUL-2064
Yield to maturity
6.26%
Maturity date
Jul 15, 2064
M
BAYZ4230946
Monsanto Company 3.95% 15-APR-2045
Yield to maturity
6.25%
Maturity date
Apr 15, 2045
B
BAYZ4804053
Bayer US Finance II LLC 3.6% 15-JUL-2042
Yield to maturity
6.23%
Maturity date
Jul 15, 2042

Explore more bonds 

Curated watchlists where BAYRY is featured.